# RYSTIGGO
> **BLA761286** · Biologics License Application · Sponsor: UCB INC · Approved 2023-06-26
## Drug
- **FDA Application Number:** BLA761286
- **Application type:** Biologics License Application
- **Brand name:** RYSTIGGO
- **Generic name:** ROZANOLIXIZUMAB
- **Active ingredients:** ROZANOLIXIZUMAB-NOLI
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** UCB INC
- **Manufacturer:** UCB, Inc.
- **First approval:** 2023-06-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761286)
---
*MORVS · CC0 1.0*